Early Phase 1 study for people with Chronic Kidney Disease

Recruiting Early Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Early Phase 1
Sponsor Cajal Therapeutics Inc.
Registry number NCT07577817
Started 1 June 2026 Today 16 October 2026 Estimated completion 1 October 2026

Past estimated completion. The registry still lists this trial as open, and the date it gave for finishing has been and gone. Confirm with the official record before you act on it.

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Nucleus Network Melbourne VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 55 Years
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 72

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Capable of giving informed consent

* Agrees to use effective contraception

* Body Mass Index (BMI) between 18.0 and 32.0 kg/m2

* Healthy by medical evaluation and medical history

* Hematological parameters, serum iron, transferrin and ferritin are within normal range and transferrin saturation is within normal range and greater than or equal to 20%

* Can swallow tablets and has suitable venous access for blood sampling

Exclusion Criteria:

* Has dietary requirements that may be difficult to accommodate

* Is a regular user of cannabis or has a history of illicit drug abuse within 1 year

* Has a history of alcohol abuse or binge drinking within 6 months

* Is a regular user of tobacco or nicotine-containing products

* Unwilling or unable to comply with the lifestyle guidelines described in the protocol

* Has clinically significant history or evidence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, neurological, immunological, or psychiatric disorder(s) as determined by the Investigator

* Has any concurrent disease or condition or physical, psychological, mental, and/or social reason that, in the opinion of the Investigator, would make the participant unsuitable for participation in the clinical study

* Has received a blood transfusion within 1 year

* Has donated whole blood within 6 months or plasma within 30 days

* Requires prescription medication or regular use of non-prescription medication

* Is an employee of the Sponsor, the CRO, or of any organization or site(s) associated with this study, or any immediate family member who is in a dependent relationship with a study site employee who is involved in the conduct of the study

Dates on the record

Started 1 June 2026
Estimated completion 1 October 2026
Registry last updated 12 June 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 12 June 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.